Search

Your search keyword '"Nasrallah, Gheyath K."' showing total 748 results

Search Constraints

Start Over You searched for: Author "Nasrallah, Gheyath K." Remove constraint Author: "Nasrallah, Gheyath K."
748 results on '"Nasrallah, Gheyath K."'

Search Results

1. Prevalence of hepatitis B and C viruses among migrant workers in Qatar

4. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient

5. Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar

9. Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months

10. Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study

12. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study

13. Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study

14. An updated overview of cyanidins for chemoprevention and cancer therapy

15. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study

18. Principal Molecular Pathways Affected in Autism Spectrum Disorder

21. Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant

24. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections

25. Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

26. Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage

33. Prevalence of hepatitis A virus among migrant workers in Qatar: A national study.

34. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

38. Performance Evaluation of a New Chemiluminescent Immunoassay for the Laboratory Diagnosis of Treponemal Antibodies

39. Hepatitis E Viruses

41. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

42. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

43. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

47. Leprosy: Comprehensive insights into pathology, immunology, and cutting-edge treatment strategies, integrating nanoparticles and ethnomedicinal plants.

48. Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.

49. Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens.

50. Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination.

Catalog

Books, media, physical & digital resources